Repare Therapeutics Inc. Quarterly Debt-to-equity in % from Q1 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Repare Therapeutics Inc. quarterly Debt-to-equity history and growth rate from Q1 2021 to Q2 2024.
  • Repare Therapeutics Inc. Debt-to-equity for the quarter ending June 30, 2024 was 17.9 %, a 41.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 17.9 -12.5 -41.2% Jun 30, 2024
Q1 2024 19.7 -13.7 -41% Mar 31, 2024
Q4 2023 25.1 -7.57 -23.2% Dec 31, 2023
Q3 2023 27.6 -4.34 -13.6% Sep 30, 2023
Q2 2023 30.4 -1.74 -5.41% Jun 30, 2023
Q1 2023 33.5 +2.62 +8.49% Mar 31, 2023
Q4 2022 32.6 +2.74 +9.17% Dec 31, 2022
Q3 2022 32 +3.02 +10.4% Sep 30, 2022
Q2 2022 32.2 +6.11 +23.5% Jun 30, 2022
Q1 2022 30.9 +6.97 +29.2% Mar 31, 2022
Q4 2021 29.9 Dec 31, 2021
Q3 2021 29 Sep 30, 2021
Q2 2021 26.1 Jun 30, 2021
Q1 2021 23.9 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.